The thromboxane A2 receptor antagonist S18886 prevents enhanced atherogenesis caused by diabetes mellitus (Q46783978)

From Wikidata
Jump to navigation Jump to search
scientific article published on 31 October 2005
edit
Language Label Description Also known as
English
The thromboxane A2 receptor antagonist S18886 prevents enhanced atherogenesis caused by diabetes mellitus
scientific article published on 31 October 2005

    Statements

    The thromboxane A2 receptor antagonist S18886 prevents enhanced atherogenesis caused by diabetes mellitus (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit